EMA intends to revise gene therapy guideline
This article was originally published in RAJ Devices
Executive Summary
The European Medicines Agency intends to revise its guideline on gene therapy medicinal products dealing with quality, non-clinical and clinical aspects to address issues in this “rapidly developing field”1.